Kumar A, Moulik N Roy, Kishore J, Kumar A, Jain A
Department of Pediatrics, Division of Pediatric Hematology-Oncology, King George's Medical University, Lucknow, Uttar Pradesh, India.
Indian J Med Microbiol. 2015 Jul-Sep;33(3):432-4. doi: 10.4103/0255-0857.158580.
Parvovirus B19 (B19V) has been associated with a wide spectrum of clinico-pathological disorders in human beings depending upon the host immunity. The present report describes a child with chronic myeloid leukemia ( CML) on hydroxyurea in haematological remission, who developed profound erythroid suppression following B19V infection requiring multiple transfusions and withdrawal of hydroxyurea. Despite being off-therapy the child remained in complete clinical and haematological remission till anti B19V antibodies appeared. This case illustrates the ability of B19V infection in suppressing neoplastic myeloid clone, a phenomenon not described earlier.
细小病毒B19(B19V)根据宿主免疫力的不同,与人类广泛的临床病理疾病相关。本报告描述了一名患有慢性髓性白血病(CML)且处于血液学缓解期、正在服用羟基脲的儿童,其在感染B19V后出现严重的红系抑制,需要多次输血并停用羟基脲。尽管停止了治疗,但该儿童在抗B19V抗体出现之前一直处于完全临床和血液学缓解状态。这个病例说明了B19V感染抑制肿瘤性髓系克隆的能力,这是一种此前未被描述过的现象。